Table 1 Maternal characteristics according to glucocorticoid treatment during pregnancy in the Puberty Cohort.

From: In Utero Exposure to Glucocorticoids and Pubertal Timing in Sons and Daughters

Glucocorticoids in pregnancy

None

ICS1/INCS12

Other3

Total

n (%)

14691 (93.2)

493 (3.1)

585 (3.7)

15769 (100.0)

Pre-pregnancy BMI4, mean (sd)

23.8 (4.5)

24.5 (5.1)

24.2 (4.9)

23.8 (4.6)

  Missings, n (%)

195 (1.3)

10 (2.0)

10 (1.7)

215 (1.4)

Maternal age at delivery in years, mean (sd)

30.6 (4.4)

31.1 (4.6)

31.0 (4.3)

30.6 (4.4)

  Missings, n (%)

6 (0.04)

0 (0.0)

0 (0.0)

6 (0.04)

Maternal age of menarche, n (%)

  Earlier than peers, n (%)

3681 (25.1)

142 (28.8)

166 (28.4)

3989 (25.3)

  Same time as peers, n (%)

8379 (57.0)

260 (52.7)

330 (56.4)

8969 (56.9)

  Later than peers, n (%)

2514 (17.1)

87 (17.7)

88 (15.0)

2689 (17.1)

  Missings, n (%)

117 (0.8)

4 (0.8)

1 (0.2)

122 (0.8)

Daily number of cigarettes in 1st trimester, n (%)

  Non-smoker, n (%)

10479 (71.3)

396 (80.3)

434 (74.2)

11309 (71.7)

  −10 cigarettes/day, n (%)

3304 (22.5)

72 (14.6)

125 (21.4)

3501 (22.2)

  >10 cigarettes/day, n (%)

857 (5.8)

23 (4.7)

26 (4.4)

906 (5.8)

  Missings, n (%)

51 (0.4)

2 (0.4)

0 (0.0)

53 (0.3)

Alcohol units per week in 1st trimester, n (%)

  0 units, n (%)

7599 (51.7)

259 (52.5)

274 (46.8)

8132 (51.6)

  >0–1 units, n (%)

4576 (31.2)

145 (29.4)

192 (32.8)

4913 (31.2)

  >1–3 units, n (%)

1743 (11.9)

62 (12.6)

94 (16.1)

1899 (12.0)

  >3 units, n (%)

752 (5.1)

26 (5.3)

25 (4.3)

803 (5.1)

  Missings, n (%)

21 (0.1)

1 (0.2)

0 (0.0)

22 (0.1)

Highest social class of parents, n (%)

  High grade professional, n (%)

3360 (22.9)

141 (28.6)

175 (29.9)

3676 (23.3)

  Low grade professional, n (%)

4823 (32.8)

161 (32.7)

192 (32.8)

5176 (32.8)

  Skilled worker, n (%)

4111 (28.0)

110 (22.3)

127 (21.7)

4348 (27.6)

  Unskilled worker, n (%)

2003 (13.6)

63 (12.8)

71 (12.1)

2137 (13.6)

  Student, n (%)

284 (1.9)

10 (2.0)

16 (2.7)

310 (2.0)

  Economically inactive, n (%)

81 (0.6)

6 (1.2)

4 (0.7)

91 (0.6)

  Missings, n (%)

29 (0.2)

2 (0.4)

0 (0.0)

31 (0.2)

Asthma in pregnancy, n (%)

  No, n (%)

14059 (95.7)

176 (35.7)

518 (88.6)

14753 (93.6)

  Yes, n (%)

628 (4.3)

317 (64.3)

67 (11.5)

1012 (6.4)

  Missings, n (%)

4 (0.03)

0 (0.0)

0 (0.0)

4 (0.03)

Allergy in pregnancy, n (%)

  No, n (%)

12957 (88.2)

163 (33.1)

306 (52.3)

13426 (85.1)

  Yes, n (%)

1692 (11.5)

328 (66.5)

277 (47.4)

2297 (14.6)

  Missings, n (%)

42 (0.3)

2 (0.4)

2 (0.3)

46 (0.3)

Skin disease in pregnancy, n (%)

  No, n (%)

13889 (94.5)

431 (87.4)

315 (53.9)

14635 (92.8)

  Yes, n (%)

749 (5.1)

59 (12.0)

267 (45.6)

1075 (6.8)

  Missings, n (%)

53 (0.4)

3 (0.6)

3 (0.5)

59 (0.4)

Muscle or joint disease in pregnancy, n (%)

  No, n (%)

13000 (88.5)

422 (85.6)

494 (84.4)

13916 (88.3)

  Yes, n (%)

1649 (11.2)

67 (13.6)

91 (15.6)

1807 (11.5)

  Missings, n (%)

42 (0.3)

4 (0.8)

0 (0.0)

46 (0.3)

  1. 1ICS: inhaled corticosteroids. 2INCS1: first-generation intranasal corticosteroids.3Other include intranasal corticosteroids second-generation, cream, tablets, injections, suppositories, eye- and eardrops. 4BMI: Body-Mass-Index.